N/A
N=45
Modulation of Fear Extinction Processes Using Transcranial Electrical Stimulation
Stress Related Disorder · Anxiety
Bottom Line
View on ClinicalTrials.gov: NCT02723188 ↗Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Galvanic Skin Response (GSR) — .45; .56; .65; .23 micro-Siemens
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Sham stimulation (1.5 milliampere,30 seconds) (Device); DC stimulation (1.5 milliampere, 20 minutes) (Device); AC stimulation (1.5 milliampere,1.5 Hertz frequency) (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Tel Aviv University
- Primary completion
- Apr 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Galvanic Skin Response (GSR) |
.45; .56; .65; .23; .54; .24 | — |
| SECONDARY Self-reported Fear Rankings |
3.8; 4.7; 5.3; 3.2; 2.5; 2.7 | — |
Summary
The aim of this study is to examine the effects of transcranial electrical stimulation on processes associated with fear extinction in healthy humans.
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
- Self-reported major psychiatric condition
- Screening specific for electrical stimulation (psychotropic medication, metal implants in head, epilepsy or seizure history)
Data sourced from ClinicalTrials.gov (NCT02723188). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.